Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06085833

ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions

Led by ARTIDIS AG · Updated on 2026-04-17

2706

Participants Needed

5

Research Sites

626 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This prospective, blinded, single-arm study aims to test the performance of nanomechanical phenotype in predicting tumor type, tumor aggressiveness, and neoadjuvant treatment response compared to the gold standard of histopathological assessment. The study involves patients with suspicious breast lesions who will undergo a breast biopsy procedure indicated by standard of care. The nanomechanical phenotype will be measured on the freshly obtained breast biopsies or tissue from breast surgeries.

CONDITIONS

Official Title

ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 65 18 years
  • Ability to understand and willingness to sign a written informed consent
  • Indication for breast biopsy for diagnostic purposes
  • ECOG performance status of 0 to 3
Not Eligible

You will not qualify if you...

  • Conditions that the investigator believes make the subject unsuitable for the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390-9020

Actively Recruiting

2

Baylor College of Medicine

Houston, Texas, United States, 77030

Actively Recruiting

3

MD Anderson Cancer Clinic - Mays Clinic

Houston, Texas, United States, 77030

Actively Recruiting

4

Hospital Universitario Vall d'Hebron

Barcelona, Barcelona, Spain, 08035

Actively Recruiting

5

Claraspital

Basel, Basel, Switzerland, CH-4058

Actively Recruiting

Loading map...

Research Team

J

Julia Ortega, DMSc, MHS, PA

CONTACT

M

Marko Loparic, MD,PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here